New York, June 16, 2014 -- Moody's Investors Service affirmed the ratings of Medtronic, Inc. following its announcement that it plans to acquire Covidien plc (debt rated at Covidien International Finance S.A.) for about $42.9 billion. Medtronic expects the transaction to close in late 2014 or early 2015, subject to regulatory and shareholder approvals. The rating outlook is stable.

Vollständigen Artikel bei Moodys lesen